These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 978210)

  • 41. Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis.
    de Bustos F; Jiménez-Jiménez FJ; Molina JA; Esteban J; Guerrero-Sola A; Zurdo M; Ortí-Pareja M; Tallón-Barranco A; Gómez-Escalonilla C; Ramírez-Ramos C; Arenas J; Enríquez de Salamanca R
    J Neural Transm (Vienna); 1998; 105(6-7):703-8. PubMed ID: 9826112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebral magnetic resonance imaging pathology and cerebro-spinal fluid protein in sporadic amyotrophic lateral sclerosis (sALS).
    Westarp ME; Schreiber H; Westarp MP; Westphal KP; Mauch E; Kornhuber HH
    Clin Neuropathol; 1995; 14(4):228-32. PubMed ID: 8521627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    De Schaepdryver M; Jeromin A; Gille B; Claeys KG; Herbst V; Brix B; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunological studies of the cerebrospinal fluid in patients with amyotrophic lateral sclerosis].
    Chankov IA; Tsanev PS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):29. PubMed ID: 1647620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
    Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
    Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis.
    Stober T; Stelte W; Kunze K
    J Neurol Sci; 1983 Sep; 61(1):21-6. PubMed ID: 6631450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis.
    Melnick JL; Seidel E; Inoue YK; Nishibe Y
    Lancet; 1982 Apr; 1(8276):830-3. PubMed ID: 6122059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. alpha-Tocopherol quinone level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
    Tohgi H; Abe T; Saheki M; Yamazaki K; Takahashi S
    Neurosci Lett; 1996 Mar; 207(1):5-8. PubMed ID: 8710208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis.
    Nociti V; Frisullo G; Marti A; Luigetti M; Iorio R; Patanella AK; Bianco A; Tonali PA; Grillo RL; Sabatelli M; Batocchi AP
    J Neuroimmunol; 2010 Aug; 225(1-2):149-52. PubMed ID: 20510468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
    Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
    Deidda I; Galizzi G; Passantino R; Cascio C; Russo D; Colletti T; La Bella V; Guarneri P
    Eur J Neurol; 2014 Mar; 21(3):478-85. PubMed ID: 24372953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis.
    Galán L; Matías-Guiu J; Matias-Guiu JA; Yáñez M; Pytel V; Guerrero-Sola A; Vela-Souto A; Arranz-Tagarro JA; Gómez-Pinedo U; García AG
    Acta Neurol Scand; 2017 Sep; 136(3):212-216. PubMed ID: 28032330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reduction in glucose concentration in the brain of mice inoculated with cerebrospinal fluid from patients with amyotrophic lateral sclerosis].
    Godoy JM; Skacel M; Lima JM; Andrade CM
    Arq Neuropsiquiatr; 1990 Dec; 48(4):473-7. PubMed ID: 2094195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes.
    Younger DS; Rowland LP; Latov N; Sherman W; Pesce M; Lange DJ; Trojaborg W; Miller JR; Lovelace RE; Hays AP
    Neurology; 1990 Apr; 40(4):595-9. PubMed ID: 2320231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatty acid changes of cerebrospinal fluid in neurological disorders as an index of changes in the blood-brain barrier.
    Pazzagli A; Arnetoli G; Pepeu I; Amaducci LA
    Neurology; 1970 Aug; 20(8):783-6. PubMed ID: 5465848
    [No Abstract]   [Full Text] [Related]  

  • 60. The cerebrospinal fluid values of advanced oxidation protein products and total thiol content in patients with amyotrophic lateral sclerosis.
    Djordjevic G; Ljubisavljevic S; Sretenovic S; Kocic G; Stojanovic I; Stojanovic S
    Clin Neurol Neurosurg; 2017 Dec; 163():33-38. PubMed ID: 29055222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.